ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Antiemetics used for prophylaxis and treatment of postoperative nausea and vomiting[1-4]

Antiemetics used for prophylaxis and treatment of postoperative nausea and vomiting[1-4]
Drug Dose[1] Timing Comments
Adults
Glucocorticoid
Dexamethasone IV: 4 to 8 mg After induction of anesthesia  
Serotonin (5-HT3) receptor antagonists
Ondansetron IV: 4 mg IV: End of surgery

May prolong QT interval.

ODT or oral soluble film may also be useful for PDNV.
Oral: 8 mg (ODT or film) Oral: 30 to 60 minutes prior to surgery
Granisetron IV: 0.35 to 3 mg End of surgery May prolong QT interval.
Dolasetron* IV: 12.5 mg End of surgery May prolong QT interval.
Tropisetron* IV: 2 mg End of surgery May prolong QT interval.
Palonosetron IV: 0.075 mg At induction of anesthesia  
Anticholinergic
Scopolamine Transdermal patch: 1.5 mg Apply several hours (eg, ≥2 hours) before anesthesia Remove 24 hours after surgery.
Antidopaminergics
Droperidol IV: 0.625 to 1.25 mg At the end of surgery May prolong QT interval; per FDA recommendation, monitor ECG for 2 to 3 hours after administration.
Haloperidol IV, IM, oral: 1 mg At the end of surgery May prolong QT interval.
Amisulpride IV, prevention: 5 mg Prevention: At induction of anesthesia

Administer over 1 to 2 minutes.

May prolong QT interval.
IV, treatment: 10 mg  
Neurokinin 1 receptor antagonists
Aprepitant Oral: 40 mg Preoperative May reduce efficacy of hormonal contraceptives.
IV: 32 mg over 30 seconds
Fosaprepitant IV: 150 mg Preoperative May reduce efficacy of hormonal contraceptives.
Rolapitant Oral: 90 mg Preoperative Long half-life; useful for prevention of PDNV.
Antihistamines
Dimenhydrinate IV: 1 mg/kg (maximum single dose: 100 mg) Optimal timing not established  
Diphenhydramine IV: 1 mg/kg (maximum single dose: 100 mg) Optimal timing not established  
Children
Glucocorticoid
Dexamethasone IV: 0.15 to 0.25[2] mg/kg (maximum dose: 4 mg) After induction  
Serotonin (5-HT3) receptor antagonists
Ondansetron IV: 0.1 mg/kg (maximum dose: 4 mg) IV: End of surgery

May repeat dose for postoperative vomiting rescue; maximum total perioperative dose: 8 mg.

ODT or oral soluble film may also be useful for PDNV[3].
Oral, children over 5 years of age[3]: 4 mg (ODT or film) Oral: 30 to 60 minutes prior to surgery
Granisetron IV: 40 mcg/kg (maximum dose: 0.6 mg) Optimal timing not established QT prolongation has been observed in pediatric patients 2 to 16 years of age.
Dolasetron* IV: 0.35 mg/kg (maximum dose: 12.5 mg) End of surgery  
Antihistamines
Dimenhydrinate IV: 0.5 mg/kg IV (maximum dose: 25 mg) Optimal timing not established  
Diphenhydramine IV: 0.5 mg/kg IV (maximum dose: 25 mg) Optimal timing not established  
Combination therapy using different classes of drugs is usually more effective than single-drug therapy for PONV prophylaxis in both children and adults. For rescue therapy after anesthesia, treatment should include a drug from a different class than those that have already been administered unless the effect of the first drug has likely worn off or a potentially inadequate dose has been administered. For additional information including administration, precautions, and drug interactions, refer to the relevant clinical topics and Lexicomp drug monographs and Lexicomp drug interactions program included within UpToDate.

ECG: electrocardiogram; FDA: United States Food and Drug Administration; IM: intramuscular; IV: intravenous; ODT: orally disintegrating tablet; PDNV: post-discharge nausea and vomiting; PONV: postoperative nausea and vomiting.

* Not available in the United States.
References:
  1. Gan TJ, Belani KG, Bergese S, et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg. 2020; 131:411-448.
  2. Madan R, Bhatia A, Chakithandy S, et al. Prophylactic dexamethasone for postoperative nausea and vomiting in pediatric strabismus surgery: a dose ranging and safety evaluation study. Anesth Analg 2005; 100:1622.
  3. Davis PJ, Fertal KM, Boretsky KR, et al. The effects of oral ondansetron disintegrating tablets for prevention of at-home emesis in pediatric patients after ear-nose-throat surgery. Anesth Analg 2008; 106:1117.
  4. Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.
Graphic 130338 Version 9.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟